Skip to main content

Pharma News

 

Clinical courses

 

Clinical research courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Dr. Reddy's Laboratories announces the acquisition of an injectable product portfolio from Eton Pharma

    Dr. Reddy's Laboratories Ltd.announced that it has acquired a portfolio of branded and generic injectable products from Deer Park, Illinois, based Eton Pharmaceuticals, Inc.

  • COVAXIN induces higher neutralising antibody response in children, says study

    New study published in Lancet Infectious Diseases suggests that Bharat Biotech COVID19 vaccine, COVAXIN induces higher neutralising antibody response in children aged 2-18 years. The company had conducted an age de-escalation study to assess the safety, reactogenicity, and immunogenicity of an inactivated COVID-19 vaccine, COVAXIN.

  • U.S. FDA issued Form 483 with six observations at Glenmark Pharma

    U.S. FDA has issued Form 483 with six observations after an inspection at Glenmark Pharma's formulation manufacturing facility based out of Baddi, India between June 13, 2022 and June 22, 2022.

    Harish Kuber, Company Secretary & Compliance Officer, Glenmark Pharma said, The Company is committed to undertake all necessary steps required to address their observations at the earliest. The Company is committed to maintaining the highest quality manufacturing standards at all of its facilities across the globe.

  • Biological E gets WHO nod for JnJ COVID vaccine production

    Biological E gets the World Health Organisation (WHO) approval to be an additional facility for production of Johnson & Johnson COVID-19 vaccine.

    The Johnson & Johnson COVID-19 vaccine consists of a replication-incompetent recombinant adenovirus type 26 (Ad26) viral vector expressing the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein in a stabilized conformation.

  • TB treatment during pregnancy is safe for mum and baby : Study finds

    Seven out of 10 pregnant women were cured of their multidrug-resistant tuberculosis and delivered healthy babies after taking a medication that had previously been considered unsafe in pregnancy, a new Curtin and Telethon Kids Institute study has found.

    Published in JAMA Network Open, the study examined the experiences of 275 pregnant women with multidrug-resistant tuberculosis living in South Africa, Peru, Brazil, Iran and Uganda.

  • Researchers develop blood test to predict liver cancer risk

    An estimated one-quarter of adults in the U.S. have nonalcoholic fatty liver disease (NAFLD), an excess of fat in liver cells that can cause chronic inflammation and liver damage, increasing the risk of liver cancer. Now, UT Southwestern researchers have developed a simple blood test to predict which NAFLD patients are most likely to develop liver cancer.

  • PCI notified that only registered pharmacists will now become president or vice president of state councils

    Pharmacy council of India set the margin to become president or vice president of state pharmacy councils. PCI notified that only registered pharmacists will now become president or vice president of state councils.

  • India not far from joining the league of top 10 in biotech : Prime Minister Narendra Modi

    Inaugurating a two-day biotechnology start-up expo and launching a portal for biotech products at Pragati Maidan here on Thursday, Prime Minister Narendra Modi expressed confidence that India was on the verge of becoming part of the top 10 countries in biotechnology. “India's bio-economy has grown eight times in the last eight years. We have grown from 10 billion dollar to 80 billion dollar. India is not too far off from reaching the league of top-10 countries in Biotech's global ecosystem”, he said.

  • Rethinking the rabies vaccine

    Rabies virus kills a shocking 59,000 people each year, many of them children. Some victims, especially kids, don’t realize they’ve been exposed until it is too late. For others, the intense rabies treatment regimen is out of the question: treatment is not widely available and the average 3,800 Dollar expense poses unthinkable economic burden for most people around the world.

  • Why vaccination against malaria quickly loses its protective effect

    Scientists from the German Cancer Research Center (DKFZ) studied the human immune response after immunization with the malaria pathogen Plasmodium falciparum. Their goal was to find out against which protein components the T helper cells induced in this way are directed. To the researchers' surprise, the T helper cells reacted exclusively to the protein sequence of the vaccine strain and showed hardly any cross-reactivity with the naturally occurring pathogen variants.

Subscribe to Pharma News